Publications Office of the EU
315/PN/2024 Supply of reagents for DNA isolation from whole blood, reagents for HLA antigen typing by real time PCR method, Terasaki platelets and reagents for B lymphocyte isolation by negative selection method for UCK - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

315/PN/2024 Supply of reagents for DNA isolation from whole blood, reagents for HLA antigen typing by real time PCR method, Terasaki platelets and reagents for B lymphocyte isolation by negative selection method for UCK Text automatically translated in your browsing language Automatically translated

  • Published
    30/12/2024
  • Deadline
    10/01/2025
  • Opening of tenders
    10/01/2025
  • Awarded
    23/04/2025
  • Today
    13/07/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Uniwersyteckie Centrum Kliniczne
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL633 Trójmiejski
Business sector (Main CPV)
33696500 Laboratory reagents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
65,717.58 PLN
Number of lots
5
Tender reference number
315/PN/2024
Description

1. The subject of the contract is the supply of DNA isolation reagents from whole blood, HLA antigen typing reagents using the real time PCR method, Terasaki platelets and B lymphocyte isolation reagents using the negative selection method for UCK in the assortment and the requirements set out in Annex 4 to the RVU. 2. Listed in pt. 1 reagents must meet the requirements set out in Annex 4 to the OTSC. Failure to meet at least one of the absolute requirements set out in Annex 4 to the CVT will result in the rejection of the tender. 3. The Ordering Party in the scope of Parts 2 and 3 requires the delivery with the first delivery of computer software suitable for the assessment of typing (CE/IVD certified) together with instructions for its use in an electronic version on a data carrier (PenDrive). 4. As part of the procedure for Parts 2 and 3, the Contractor is obliged to provide ongoing technical assistance in the implementation of the procedure and analysis of the results and in the proper functioning of the database with the results obtained using the offered tests/reagents. 5. As part of the procedure for Parts 2 and 3, the Contractor is obliged to conduct full training at the HLA Laboratory of Immunology and Clinical Transplantology UCK in the following areas: • Procedures and applications of offered tests • All stages of testing • Analysis of results 6. For the purposes of the training, the Contractor will provide a complete set of reagents, calibrators, controls, parts and consumables and other reagents and accessories necessary to select HLA for 24 tests on the Quant Studio 6 camera owned by the Ordering Party. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://portal.smartpzp.pl/uck.gdansk/public/postepowanie?postepowanie=76839827
Tenders may be submitted
Electronic submission: required
https://portal.smartpzp.pl/uck.gdansk/public/postepowanie?postepowanie=76839827
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
10/01/2025 10:00
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.